Issue: 2003 > July > review

Ribavirin in the treatment of severe acute respiratory syndrome (SARS)

M.G.A. van Vonderen, J.C. Bos, J.M. Prins, P. Wertheim-van Dillen, P. Speelman


Severe acute respiratory syndrome (SARS) has recently been recognised as a newly emerging infectious disease with significant morbidity and mortality. It has been suggested that (early) antiviral treatment with ribavirin and high-dose glucocorticosteroids may be beneficial. We have summarised the available data on ribavirin to facilitate decision-making when confronted with (suspected) SARS.